{"retracted":true,"timestamp":1417392000000,"update":{"timestamp":null,"doi":null,"pmid":26195291,"type":"retraction"},"doi":"10.1007/s12032-014-0251-x","journal":"Medical oncology (Northwood, London, England)","publisher":null,"title":"A randomized phase II study of everolimus for advanced pancreatic neuroendocrine tumors in Chinese patients."}
